{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:59:50Z","timestamp":1768399190676,"version":"3.49.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jfo.2015.06.006","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T07:53:03Z","timestamp":1446537183000},"page":"924-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Traitements compar\u00e9s de la n\u00e9ovascularisation corn\u00e9enne\u00a0: injections sous-conjonctivales de b\u00e9vacizumab et\/ou phototh\u00e9rapie dynamique"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9366-4302","authenticated-orcid":false,"given":"J.","family":"Hamdan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hoffart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2015.06.006_bib0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0010","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0015","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/archopht.1983.01040010640024","article-title":"Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization","volume":"101","author":"Phillips","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0020","first-page":"2510","article-title":"Inhibition of inflammatory corneal amniogenesis by TNP-470","volume":"42","author":"Joussen","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0025","first-page":"476","article-title":"Thalidomide prevents donor corneal graft neovascularization in an alkali burn model of corneal angiogenesis","volume":"52","author":"Abbas","year":"2002","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jfo.2015.06.006_bib0030","first-page":"2498","article-title":"Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules","volume":"40","author":"Duenas","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topical application of methotrexate for inhibition of corneal angiogenesis","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0040","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/archopht.120.8.1063","article-title":"Angiostatin inhibits and regresses corneal neovascularization","volume":"120","author":"Ambati","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","article-title":"Inhibition of experimental angiogenesis of cornea by somatostatin","volume":"241","author":"Wu","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0050","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.03-0940","article-title":"Roles of thrombospondin- 1\u00a0and\u20132\u00a0in regulating corneal and iris angiogenesis","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0055","first-page":"28","article-title":"Inhibition of corneal angiogenesis by local application of vasostatin","volume":"11","author":"Wu","year":"2005","journal-title":"Mol Vis"},{"key":"10.1016\/j.jfo.2015.06.006_bib0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.exer.2004.10.009","article-title":"Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand","volume":"80","author":"Sarayba","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2015.06.006_bib0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/emm.2006.21","article-title":"Inhibition of corneal neovascularization by rapamycin","volume":"38","author":"Kwon","year":"2006","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jfo.2015.06.006_bib0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.gt.3302442","article-title":"Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1\u00a0gene reduces corneal neovascularization in an in vivo rabbit model","volume":"12","author":"Yoon","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.jfo.2015.06.006_bib0075","first-page":"1975","article-title":"Rapid ocular angiogenic control via naked DNA delivery to cornea","volume":"42","author":"Stechschulte","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1167\/iovs.02-0685","article-title":"Sustained inhibition of corneal neovascularization by genetic ablation of CCR5","volume":"44","author":"Ambati","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0085","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/archopht.1989.01070020575043","article-title":"Promotion of graft survival by photothrombotic occlusion of corneal neovascularization","volume":"107","author":"Corrent","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0090","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ajo.2007.05.028","article-title":"Photodynamic therapy with verteporfin for corneal neovascularization","volume":"144","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0095","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjo.2003.035071","article-title":"Photodynamic therapy for corneal neovascularization and lipid degeneration","volume":"88","author":"Brooks","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2\u00a0randomized clinical trials-TAP report","volume":"117","author":"Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/02713680600559564","article-title":"Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin","volume":"31","author":"Yoon","year":"2006","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2015.06.006_bib0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.06.006_bib0115","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0120","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archopht.125.6.834","article-title":"Topical bevacizumab therapy for corneal neovascularization","volume":"125","author":"DeStafeno","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"245","author":"Erdurmus","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0130","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1755-3768.2008.01399.x","article-title":"Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization","volume":"87","author":"You","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0135","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e31817786ad","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"27","author":"Doctor","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.06.006_bib0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2015.06.006_bib0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajo.2006.01.085","article-title":"Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy","volume":"142","author":"Tatar","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0150","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2008.08.007","article-title":"Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts","volume":"87","author":"Bock","year":"2008","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2015.06.006_bib0155","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101\u00a0antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.06.006_bib0160","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","article-title":"Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival","volume":"51","author":"Dastjerdi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2015.06.006_bib0165","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jfo.2013.04.006","article-title":"Imagerie et quantification de la n\u00e9ovascularisation corn\u00e9enne","volume":"36","author":"Benayoun","year":"2013","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/IAE.0b013e31816b316e","article-title":"Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration","volume":"28","author":"Smith","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2015.06.006_bib0175","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2015.06.006_bib0180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1755-3768.2009.01585.x","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"88","author":"Zaki","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0190","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jfo.2015.06.006_bib0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1442-9071.2010.02252.x","article-title":"Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone","volume":"38","author":"Hoffart","year":"2010","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2015.06.006_bib0200","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Subconjunctival bevacizumab for vascularized rejected corneal grafts","volume":"33","author":"Awadein","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.jfo.2015.06.006_bib0205","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/ICO.0b013e3181dc81a0","article-title":"Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization","volume":"30","author":"You","year":"2011","journal-title":"Cornea"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551215003459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551215003459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:06:15Z","timestamp":1759259175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551215003459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0181551215003459"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2015.06.006","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitements compar\u00e9s de la n\u00e9ovascularisation corn\u00e9enne\u00a0: injections sous-conjonctivales de b\u00e9vacizumab et\/ou phototh\u00e9rapie dynamique","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2015.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}